MANÜ Telehealth Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: semaglutide at $120/month, 44% below the typical price
MANÜ Telehealth falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked June 2026
GLP-1s are advertised from about $4 to $5/day. MANÜ Telehealth sells compounded weight loss medication, injectable tirzepatide and semaglutide, with MIC Ultraburn and NAD+ injections offered as add-ons; US 503A pharmacies do the compounding. The US platform keeps the process 100% online, with monthly check-ins, board-certified physicians, free shipping and no insurance required. Which states are served can change; signup confirms it. Hormone optimization gets a mention but is not the primary focus. Compounded medications here are not FDA-evaluated.
Is MANÜ Telehealth legit?
Yes. MANÜ Telehealth is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MANÜ Telehealth promo or coupon code?
We know of no promo or coupon code for MANÜ Telehealth. Its listed price is $120 a month. Coupon sites advertising "MANÜ Telehealth discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MANÜ Telehealth compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to MANÜ Telehealth
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
MANÜ Telehealth at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded tirzepatide, Compounded semaglutide
- Starting price
- $120/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How MANÜ Telehealth scores
Six columns, each one computed from something MANÜ Telehealth has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
8.7/10$150/month is 40% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MANÜ Telehealth
Last checked June 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for MANÜ Telehealth
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MANÜ Telehealth involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MANÜ Telehealth shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask MANÜ Telehealth which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: tirzepatide $150, semaglutide $120. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that MANÜ Telehealth serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting MANÜ Telehealth
- Phone
- +1 (786) 460-9055
- MANÜ Telehealth offers email support
GLP-1 medications MANÜ Telehealth offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides MANÜ Telehealth offers
MANÜ Telehealth sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off MANÜ Telehealth's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $150 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
- Semaglutide costs $120 a month, 35% below the $185 median for compounded semaglutide across the sellers we compare
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to MANÜ Telehealth
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MANÜ Telehealth charges
MANÜ Telehealth charges $120/month.
- Compounded tirzepatide: $150/month
- Compounded semaglutide: $120/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so MANÜ Telehealth's $150 is genuinely below the middle, not just advertised that way.
Oak dispenses semaglutide and tirzepatide from $119/month, which makes it the fair comparison to run before you commit here.
What MANÜ Telehealth dispenses
MANÜ Telehealth prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
Before you start an intake, ask MANÜ Telehealth which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to MANÜ Telehealth. The pharmacy question matters most here because the medication is compounded. If MANÜ Telehealth will not name the pharmacy, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MANÜ Telehealth bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
MANÜ Telehealth competes on price: $150/month for compounded tirzepatide. The catch is disclosure, which is why MANÜ Telehealth scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
MANÜ Telehealth falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay MANÜ Telehealth
Starting at $120 a month. Check today's price, then start the intake.
Where MANÜ Telehealth is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare MANÜ Telehealth head to head
The sellers closest to MANÜ Telehealth on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MANÜ Telehealth review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of June 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MANÜ Telehealth's current pricing
Plans start at $120 a month. Whether you qualify is a clinician's decision, made after your intake.